OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Dr. Sjogren joins DiaGenic as CMO from 1st September 2011 and will be part of the management team and responsible for the global clinical diagnostic programs and strategies of DiaGenic. Prior to joining DiaGenic ASA he was Vice President Global Exploratory Development at UCB Pharma SA in Belgium and UK and before that has had executive and senior scientific positions at Schering-Plough, Organon and AstraZeneca. He is Associate Professor since 2002 with a PhD in Clinical Psychiatry in 1999 at Gothenburg University, Sweden.
